Picture of Biomx logo

PHGE Biomx Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Biomx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
June 30th
2019
June 30th
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
Net Income/Starting Line-0.0010.347-30.1-36.2
Depreciation
Deferred Taxes
Non-Cash Items-0.8813.012.98
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.0010.330.4533.1
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities-0-0.205-24.4-27.6
Capital Expenditures-1.01-3.68
Purchase of Fixed Assets
Other Investing Cash Flow Items-70-9.8519.9
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Cash from Investing Activities-70-10.916.2
Financing Cash Flow Items-0.0250.241-0.075
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities070.90.13437.3
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash00.696-35.225.9

Or unlock with your email

Or unlock with your email